BioAtla | IPO Presentation Deck | 31 slides · page 23 of 31
The slide compares efficacy (tumor volume) and safety (GI symptoms) of BA3071 against standard I/O therapies.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 legend 1/1 list 1/1 title 1/1
Components 5
dot line legend bullet headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.